Acasti Announces Preliminary Topline Results Met All Outcome Measures in the Pharmacokinetic Bridging Study for GTX-102, the Company’s Drug Candidate for the Treatment of Ataxia Telangiectasia
LAVAL, Québec, Dec. 28, 2022 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”)…
Everest Medicines Reports 1H 2026 Results, Enters New Phase as Growth Accelerates and Innovation Gains Momentum
Aurentis Capital Group Announces Technology-Driven Trading Platform for Global Markets
TMX Group Limited Completes Acquisition of RAFI Indices from Research Affiliates
Focus Graphite Chairman Converts Final C$835,000 Loan to Equity at a Premium to Market
Hong Kong emerges as top professional services platform for Mainland enterprises going global